Search clinical trials for: Relapsed/refractory multiple myeloma
Total 12937 results
-
Ichnos Sciences SANot yet recruitingRelapsed/Refractory Multiple MyelomaAustralia
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
Karyopharm Therapeutics IncWithdrawn
-
Celularity IncorporatedCompleted
-
Alaunos TherapeuticsCompletedLymphoma | Multiple Myeloma | Acute Leukemia | Chronic Myeloproliferative Disease | Chronic Lymphoproliferative Disease | Poor-risk Myelodysplasia (MDS)United States
-
Shenzhen Geno-Immune Medical InstituteThe No.2 Clinical Hospital of the Ministry of HealthRecruitingMultiple Myeloma | PlasmacytomaChina, Russian Federation
-
Janssen Research & Development, LLCNot yet recruitingRelapsed or Refractory Multiple Myeloma
-
Ontario Clinical Oncology Group (OCOG)PfizerNot yet recruitingRefractory Multiple MyelomaCanada
-
Nantes University HospitalNot yet recruiting
-
Kite, A Gilead CompanyArcellx, Inc.Not yet recruiting
-
Jules Bordet InstituteRayzeBio, Inc.Not yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma ProgressionBelgium
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Newly Diagnosed | MRD | High Risk
-
University Hospital, AngersNot yet recruiting
-
Shanghai Changzheng HospitalCARsgen Therapeutics Co., Ltd.Not yet recruitingHigh-risk Newly Diagnosed Multiple Myeloma (HRNDMM)
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Janssen Research & Development, LLCNot yet recruitingLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Myelofibrosis | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Hematologic Malignancy | Aplastic Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Bone Marrow Transplant Rejection | Acute Lymphoblastic Leukemia (ALL), Adult
-
Peking University First HospitalRecruiting
-
IRCCS Policlinico S. MatteoRecruitingAL Amyloidosis | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaItaly
-
Cullinan Therapeutics Inc.Not yet recruiting
-
Changzhou No.2 People's HospitalNot yet recruiting
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.Not yet recruitingRelapsed or Refractory Multiple MyelomaChina
-
Dickran Kazandjian, MDRegeneron PharmaceuticalsNot yet recruiting
-
Peking University People's HospitalNot yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
Tufts Medical CenterNational Cancer Institute (NCI)Not yet recruitingSmoldering Multiple MyelomaUnited States
-
Wuhan Union Hospital, ChinaNot yet recruitingMultiple Myeloma
-
Bristol-Myers SquibbRecruitingMultiple Myeloma | Non-Hodgkin Lymphoma | Chronic Lymphocytic LeukaemiaBelgium
-
SanofiNot yet recruiting
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
Jack KhouriNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Cytokine Release Syndrome | Immune Effector Cell Associated Neurotoxicity SyndromeUnited States
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingLymphoma, B-Cell | Multiple Myeloma | Acute Lymphoblastic Leukemia | Hematologic Malignancy | Car T- CellFrance
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingMultiple Myeloma | Newly Diagnosed Multiple Myeloma | Autologous Stem Cell TransplantationUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); The Foundation for Barnes-Jewish HospitalRecruitingMultiple Myeloma | Rectal Cancer | Cholangiocarcinoma | Colon CancerUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Not yet recruiting
-
CARsgen Therapeutics Co., Ltd.Not yet recruitingMultiple Myeloma | Primary Plasma Cell Leukemia
-
Emory UniversityNational Cancer Institute (NCI); National Center for Complementary and Integrative...RecruitingLymphoma | Multiple MyelomaUnited States
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Jinling Hospital, ChinaRecruitingNewly Diagnosed Multiple MyelomaChina
-
The Christie NHS Foundation TrustCellCentric Ltd.Not yet recruitingMultiple MyelomaUnited Kingdom
-
Leuko Labs, Inc.Not yet recruitingMultiple Myeloma | Diffuse Large B Cell Lymphoma
-
RenJi HospitalShanghai JMT-Bio Inc.Not yet recruitingMultiple Myeloma | Bone Diseases
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Institute of Hematology & Blood Diseases Hospital...Recruiting
-
Guangdong Second Provincial General HospitalNot yet recruitingRelapsed or Refractory Multiple MyelomaChina
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingMultiple MyelomaUnited States, Canada
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingLymphoma | Leukemia | Multiple Myeloma | Hematologic Malignancies | Blood CancersUnited States